SCHEMBL979218

SCHEMBL979218

CCCCCCCCCCOc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 11/20 0.72
RARG P13631 8/20 0.72
RARA P10276 5/20 0.72
MEN1 O00255 3/20 0.72
KMT2A Q03164 3/20 0.72
NR1I2 O75469 1/20 0.72
LMNA P02545 1/20 0.72
PGR P06401 1/20 0.72
HSPD1 P10809 1/20 0.72
GOT1 P17174 1/20 0.72
GLRA1 P23415 1/20 0.72
BLM P54132 1/20 0.72
HSPE1 P61604 1/20 0.72
TDP1 Q9NUW8 1/20 0.72
KDM4E B2RXH2 1/20 0.62
ALDH1A1 P00352 1/20 0.62
TP53 P04637 1/20 0.62
CYP3A4 P08684 1/20 0.62
MAPT P10636 1/20 0.62
HPGD P15428 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL980744 1.00 RARB (0.72) RARBRARGRARAMEN1KMT2A
SCHEMBL3803050 0.91 RARB (0.63) RARBRARGRARAMEN1KMT2A
SCHEMBL3801401 0.91 RARB (0.63) RARBRARGRARAMEN1KMT2A
SCHEMBL7521122 0.90 MEN1 (0.61) RARBRARGRARAMEN1KMT2A
SCHEMBL5081246 0.90 RARB (0.74) RARBRARGRARAMEN1KMT2A
SCHEMBL9133374 0.90 RARA (0.55) RARBRARGRARAMEN1KMT2A
SCHEMBL8767123 0.89 RARG (0.70) RARBRARGRARAMEN1KMT2A
Hydrochloric Acid SCHEMBL9133769 0.88 RARA (0.54) RARBRARGRARAMEN1KMT2A
Hydrochloric Acid SCHEMBL8765869 0.88 RARG (0.69) RARBRARGRARAMEN1KMT2A
SCHEMBL8766163 0.85 RARG (0.74) RARBRARGRARAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020068665-A1 USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN FABIUS BIOTECHNOLOGY (US) 2020-04-02 WO claimed
EP-2224908-B1 COMPOSITIONS CONTAINING AT LEAST ONE NAPHTHOIC ACID DERIVATIVE, BENZOYL PEROXIDE AND AT LEAST ONE FILM-FORMING AGENT, METHODS FOR PREPARING SAME AND USES THEREOF GALDERMA RES & DEV (FR) 2017-11-01 EP claimed
EP-2364692-B1 Compositions including at least one derivative of naphtoic acid, benzoyl peroxide and at least one film-forming agent, methods for preparing same and uses thereof GALDERMA RES & DEV (FR) 2017-10-25 EP claimed
US-20150342920-A1 DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE GALDERMA RESEARCH & DEVELOPMENT (FR) 2015-12-03 US claimed
EP-2416768-B1 COMPOSITIONS COMPRISING AT LEAST ONE COMPLEX COMPOSED OF A DERIVATIVE OF NAPHTHOIC ACID AND OF AT LEAST ONE CYCLODEXTRIN AND USES THEREOF GALDERMA RES & DEV (FR) 2015-10-07 EP claimed
US-20150216834-A1 PHARMACEUTICAL/COSMETIC, E.G., ANTI-ACNE COMPOSITIONS COMPRISING AT LEAST ONE NAPHTOIC ACID COMPOUND, BENZOYL PEROXIDE AND AT LEAST ONE FILM-FORMING AGENT GALDERMA RESEARCH & DEVELOPMENT (FR) 2015-08-06 US claimed
US-20150098918-A1 CREAM GELS COMPRISING AT LEAST ONE RETINOID AND BENZOYL PEROXIDE GALDERMA RESEARCH & DEVELOPMENT (FR) 2015-04-09 US claimed
EP-2167062-B1 Compositions and uses comprising a retinoid compound, an anti-irritant compound and benzoyl peroxide in acne GALDERMA RES & DEV (FR) 2015-02-18 EP claimed
US-8937098-B2 Dermatological compositions comprising at least one naphthoic acid compound and at least one film-forming agent and treatment of keratinization disorders therewith GALDERMA RESEARCH & DEVELOPMENT (FR) 2015-01-20 US claimed
EP-2029133-B1 COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOIC ACID DERIVATIVE AND AT LEAST ONE FILM-FORMING AGENT, METHODS FOR PREPARING SAME, AND USES THEREOF GALDERMA RES & DEV (FR) 2014-11-05 EP claimed
US-20090247630-A1 DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOIC ACID COMPOUND AND AT LEAST ONE FILM-FORMING AGENT AND TREATMENT OF KERATINIZATION DISORDERS THEREWITH GALDERMA RESEARCH & DEVELOPMENT (FR) 2009-10-01 US claimed
US-20090191245-A1 REDUCED-IRRITANT DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOIC ACID COMPOUND AND BENZOYL PEROXIDE AND TREATMENT OF KERATINIZATION DISORDERS THEREWITH GALDERMA RESEARCH & DEVELOPMENT (FR) 2009-07-30 US claimed
US-20090098219-A1 Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith GALDERMA RESEARCH & DEVELOPMENT (FR) 2009-04-16 US claimed
US-20090012172-A1 Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith GALDERMA RESEARCH & DEVELOPMENT (FR) 2009-01-08 US claimed
WO-2008152064-A1 COMPOSITIONS AND USES COMPRISING A RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE IN ACNE GALDERMA RESEARCH & DEVELOPMENT (FR) 2008-12-18 WO claimed
WO-2008152065-A1 COMPOSITION AND USES OF A RETINOID, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE, IN ACNE GALDERMA RESEARCH & DEVELOPMENT (FR) 2008-12-18 WO claimed
US-20080253986-A1 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers GALDERMA RESEARCH & DEVELOPMENT (FR) 2008-10-16 US claimed
EP-1933827-A2 COMPOSITION COMPRISING AT LEAST ONE NAPHTHOIC ACID DERIVATIVE AND AT LEAST ONE COMPOUND OF POLYURETHANE POLYMER TYPE OR DERIVATIVES THEREOF, PREPARATION PROCESSES THEREFOR AND USES THEREOF Galderma Research & Development, S.N.C. (FR) 2008-06-25 EP claimed
WO-2007031883-A2 COMPOSITION COMPRISING AT LEAST ONE NAPHTHOIC ACID DERIVATIVE AND AT LEAST ONE COMPOUND OF POLYURETHANE POLYMER TYPE OR DERIVATIVES THEREOF, PREPARATION PROCESSES THEREFOR AND USES THEREOF GALDERMA RESEARCH & DEVELOPMENT (FR) 2007-03-22 WO claimed
EP-0199636-B1 BENZONAPHTHALENIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN PHARMACY AND COSMETICS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES C.I.R.D. Groupement d'Intérêt Economique dit: (FR) 1989-02-08 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150216834-A1 PHARMACEUTICAL/COSMETIC, E.G., ANTI-ACNE COMPOSITIONS COMPRISING AT LEAST ONE NAPHTOIC ACID COMPOUND, BENZOYL PEROXIDE AND AT LEAST ONE FILM-FORMING AGENT PAOX, CUTA, ACOX1 RARB 155/4885RARG 114/4885RARA 78/4885
US-20090247630-A1 DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOIC ACID COMPOUND AND AT LEAST ONE FILM-FORMING AGENT AND TREATMENT OF KERATINIZATION DISORDERS THEREWITH CUTA, NOTUM, KRT18 RARB 25/4885RARG 29/4885RARA 5/4885
US-20090191245-A1 REDUCED-IRRITANT DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOIC ACID COMPOUND AND BENZOYL PEROXIDE AND TREATMENT OF KERATINIZATION DISORDERS THEREWITH CUTA, KRT18, RARA RARB 6/4885RARG 9/4885RARA 3/4885
US-20080253986-A1 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers CUTA, NACA, PUF60 RARB 136/4885RARG 126/4885RARA 58/4885
US-20090012172-A1 Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith KRT18, RARA, RARB RARB 3/4885RARG 4/4885RARA 2/4885
US-20090098219-A1 Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith RARA, RARB, RARG RARB 2/4885RARG 3/4885RARA 1/4885
US-20150342920-A1 DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE RARB, RARA, RARG RARB 1/4885RARG 3/4885RARA 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.